Newborn Screening of Inherited Metabolic Diseases by NGS

Next generation sequencing panel for non-invasive prenatal testing (NIPT) and newborn screening (NBS). Provides precision genetic profiling for maternal and pediatric healthcare applications.

Next-generation sequencing testing kit for comprehensive genomic analysis and variant detection. Enables high-throughput sequencing for applications in molecular diagnostics and research.

NGS kits for next-generation sequencing-based molecular diagnostics of oncology, infectious disease, genetic disorders, and chronic conditions. Enables precision detection, disease diagnosis, pharmacogenomic profiling, and treatment monitoring across clinical and research settings.

Sequencing panel for identifying genetic variations associated with hereditary and congenital disorders. Enables comprehensive genetic disease diagnosis.

Next-generation sequencing diagnostic kits developed and manufactured for genomic analysis and sequencing applications. Provides complete kit solutions including reagents, components, and assembly with full GMP compliance.

Next-generation sequencing services for research and diagnostic applications including metagenomic profiling, viral surveillance, and molecular analysis. Supported by specialized collection kits and purification protocols.

Targeted sequencing panels designed for longitudinal patient monitoring and treatment response assessment. Enables detection of minimal residual disease and tracking of genomic changes over time to inform ongoing clinical management.

iGenetech NGS kits enable next-generation sequencing for genomic analysis and molecular diagnostics. These kits support clinical applications including genetic testing, disease screening, and precision medicine workflows. Complete reagent systems designed for laboratory-based sequencing platforms.

Comprehensive screening platform for early detection of genetic and metabolic disorders in newborns. Delivers rapid, accurate results to support timely clinical intervention and improved patient outcomes.

Precision medicine screening platform for early detection of genetic and metabolic disorders in newborns.

Comprehensive screening tests for detection of inborn errors of metabolism in neonates, identifying genetic and metabolic disorders within the first days of life to enable early intervention.

Comprehensive newborn screening solution combining diagnostic kits, instruments, and software for early detection of rare congenital and metabolic diseases. Enables laboratories to identify genetic predispositions and support pharmacogenetic testing without DNA extraction requirements, streamlining workflow from sample collection to clinical results.